Quantcast

Latest InspireMD Inc. Stories

2014-08-11 08:28:58

Results will be announced on Tuesday, September 16 in Washington, D.C. BOSTON, Aug. 11, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that Professor Joachim Schofer, MD, at the Hamburg University Cardiovascular Center, will present the results of the CARENET (CARotid Embolic protection using microNET) trial at the Transcatheter Cardiovascular Therapeutics (TCT) conference, in...

2014-07-17 08:29:39

BOSTON, July 17, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, announced today that it will release its financial results for the second quarter ended June 30, 2014 on Wednesday, July 23(rd). The Company will host a conference call at 4:30 p.m. ET on Wednesday, July 23(rd) to review its financial results and business outlook. Participants should call (877) 407-0784 (United States) or (201) 689-8560...

2014-07-15 08:28:52

Strengthens Leadership Team with Addition of Experienced Medical Device Executive BOSTON, July 15, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, today announced the appointment of James Barry, Ph.D. as Chief Operating Officer. Barry, who has more than two decades of experience in the medical device industry, will be based in the Company's Boston headquarters. Dr. Barry will focus on three critical...

2014-07-08 08:31:38

100% procedural success rate achieved in first multi-specialty clinical experience BOSTON, July 8, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that it has concluded enrollment in its CARENET clinical trial. The multi-specialty (Interventional Cardiologists, Interventional Radiologists and Vascular Surgeons) trial is assessing the peri-procedural safety and efficacy of CGuard...

2014-07-01 08:30:24

BOSTON, July 1, 2014 /PRNewswire/ -- InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, today announced that it has been selected to join the Russell Microcap Index, as of June 27, 2014. Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective,...

2014-06-23 08:29:30

BOSTON, June 23, 2014 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems (EPS), today announced that it received European regulatory approval to resume the manufacturing of its MGuard Prime EPS stent with a modified stent securement process . The Company also received approval to modify and re-deploy existing MGuard Prime EPS stents that have been returned by clinical and commercial sites worldwide. The European...

2014-06-18 08:29:29

BOSTON, June 18, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo, will be presenting at the 9(th) Annual JMP Securities Healthcare Conference at the Westin New York Grand Central in New York. The Company will present at 11:00 a.m. ET on Wednesday, June 25, 2014. Investors attending the conference who wish to meet with InspireMD management for one-on-one meetings are encouraged to contact their JMP...

2014-05-20 08:33:34

Company to Present at European Symposium Titled MGuard(TM) Embolic Protection Stent: The Importance of Thrombus Management in STEMI Primary PCI BOSTON, May 20, 2014 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that it will be attending EuroPCR 2014, the leading cardiovascular event in Europe. The conference will take place in Paris, France from May 20-23, 2014. Each year, more than 120...

2014-05-09 08:26:45

BOSTON, May 9, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo, will be presenting at the Bank of America Merrill Lynch 2014 Health Care Conference at the Encore at Wynn Las Vegas. The Company will present at 12:00 p.m. PT on Thursday, May 15, 2014. Investors unable to attend the conference may listen in to the webcast, which can be found on the Investors section of the Company's website at...

2014-04-30 20:23:54

NEW YORK, April 30, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR) (CUSIP: 45779A101). Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The investigation concerns whether InspireMD and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. On April 30, 2014...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related